Search - tctmd.com

Displaying 1 - 20 of 147

Sort: Relevancy | Date

News Daily News

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Yael L. Maxwell

December 23, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Ron Waksman

November 01, 2016

Presentation TCT 2016

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

Presenter: Stephen G. Ellis, Patrick W. Serruys, Ron Waksman

November 01, 2016

Presentation TCT 2016

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer

Presenter: Gregg W. Stone, Ron Waksman, John A. Ambrose

November 01, 2016

Presentation TCT 2016

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque

Presenter: Gregg W. Stone, Ron Waksman, Jonathan Leor

November 01, 2016

Presentation TCT 2016

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly

November 01, 2016

Presentation TCT 2016

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT

Presenter: Gregg W. Stone, Ron Waksman, Seung-Jung Park

November 01, 2016

Presentation TCT 2016

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq

November 01, 2016

Presentation TCT 2016

Back to BRS: Falcon, the Next Generation

Presenter: Ron Waksman, Robert-Jan van Geuns, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

BRS Snapshots: A Novel Biodegradable FE/316L Stent

Presenter: Ron Waksman, Robert-Jan van Geuns, Olivier F. Bertrand

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Lifetech Iron-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Runlin Gao

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ArterioSorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

BRS Snapshots: The Biolute BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Dinesh Shah

October 31, 2016

Presentation TCT 2016

BRS Snapshots: XINSORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Lei Ge

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

Presenter: Ron Waksman, Robert-Jan van Geuns, Antoine Lafont

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Renuvia FAST

Presenter: Ron Waksman, Robert-Jan van Geuns, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

Presenter: Ron Waksman, Robert-Jan van Geuns, Guosheng Fu

October 31, 2016

Presentation TCT 2016

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Juan F. Granada

October 31, 2016

Presentation TCT 2016

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results

Presenter: Ron Waksman, Robert-Jan van Geuns, Bo Xu

October 31, 2016

Presentation TCT 2016

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Advertisement

Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label?

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Metallic Versus Polymeric BRS: Differences In Mechanical Properties and Preclinical Bench Testing

My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer

Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque

Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner?

To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT

Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?!

Back to BRS: Falcon, the Next Generation

BRS Snapshots: A Novel Biodegradable FE/316L Stent

BRS Snapshots: Lifetech Iron-Based BRS

BRS Snapshots: ArterioSorb

BRS Snapshots: The Biolute BRS

BRS Snapshots: XINSORB

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

BRS Snapshots: Renuvia FAST

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

From APTITUDE to MAGNITUDE: Progress Towards the Development of a Thin-walled Novel PLLA-based Polymeric BRS

FIRESORB PLLA-Based Sirolimus-Eluting Scaffold: 6-Month FUTURE-I Results

MIRAGE: Design Novelty and 1-Year Results With a Microfiber-Based BRS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content